Eris Lifesciences allots 33,287 equity shares under ESOP
06 - Mar - 2025 12:00 | 36 days ago
Eris Lifesciences has allotted 33,287 equity shares under ESOP on 06 March 2025. The paid-up share capital of the Company accordingly stands increased from Rs. 13,61,29,282/- (13,61,29,282 equity shares of Re. 1/- each) to Rs. 13,61,62,569/- (13,61,62,569 equity shares of Re. 1/- each).
Eris Lifesciences avails credit facility of Rs 1,000 cr
21 - Feb - 2025 12:00 | 49 days ago
Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahindra Bank (Bank). The aggregate debt level of the company would remain unchanged.
Board of ERIS Lifesciences recommends Interim Dividend
07 - Feb - 2025 12:00 | 63 days ago
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
Eris Lifesciences avails credit facility of Rs 1,000 cr
21 - Feb - 2025 12:00 | 49 days ago
Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahindra Bank (Bank). The aggregate debt level of the company would remain unchanged.
Board of ERIS Lifesciences recommends Interim Dividend
07 - Feb - 2025 12:00 | 63 days ago
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
Eris Lifesciences allots 33,287 equity shares under ESOP
06 - Mar - 2025 12:00 | 36 days ago
Eris Lifesciences has allotted 33,287 equity shares under ESOP on 06 March 2025. The paid-up share capital of the Company accordingly stands increased from Rs. 13,61,29,282/- (13,61,29,282 equity shares of Re. 1/- each) to Rs. 13,61,62,569/- (13,61,62,569 equity shares of Re. 1/- each).
Eris Lifesciences avails credit facility of Rs 1,000 cr
21 - Feb - 2025 12:00 | 49 days ago
Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahindra Bank (Bank). The aggregate debt level of the company would remain unchanged.
Board of ERIS Lifesciences recommends Interim Dividend
07 - Feb - 2025 12:00 | 63 days ago
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
Eris Lifesciences allots 33,287 equity shares under ESOP
06 - Mar - 2025 12:00 | 36 days ago
Eris Lifesciences has allotted 33,287 equity shares under ESOP on 06 March 2025. The paid-up share capital of the Company accordingly stands increased from Rs. 13,61,29,282/- (13,61,29,282 equity shares of Re. 1/- each) to Rs. 13,61,62,569/- (13,61,62,569 equity shares of Re. 1/- each).
Eris Lifesciences avails credit facility of Rs 1,000 cr
21 - Feb - 2025 12:00 | 49 days ago
Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahindra Bank (Bank). The aggregate debt level of the company would remain unchanged.
Board of ERIS Lifesciences recommends Interim Dividend
07 - Feb - 2025 12:00 | 63 days ago
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
Eris Lifesciences avails credit facility of Rs 1,000 cr
21 - Feb - 2025 12:00 | 49 days ago
Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahindra Bank (Bank). The aggregate debt level of the company would remain unchanged.
Board of ERIS Lifesciences recommends Interim Dividend
07 - Feb - 2025 12:00 | 63 days ago
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.
